, Tracking Stock Market Picks
Enter Symbol:
Furiex Pharmaceuticals, Inc. (FURX) [hlAlert]

up 606.95 %

FURIEX PHARMACEUTICALS INC. (FURX) rated Buy with price target $18 by Global Hunter Securities

Posted on: Friday,  Oct 21, 2011  8:25 AM ET by Global Hunter Securities

Global Hunter Securities rated Buy Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) on 10/21/2011, when the stock price was $14.82.
Since then, Furiex Pharmaceuticals, Inc. has gained 606.95% as of 07/01/2014's recent price of $104.77.
If you would have followed this Global Hunter Securities's recommendation on FURX, you would have gained 606.95% of your investment in 984 days.

Furiex Pharmaceuticals, Inc. is a drug development collaboration company. The Company?s product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Its programs include Priligy, Alogliptin Nesina, Alogliptin/Actose Combination, Alogliptin/Metformin Combination, Fluoroquinolone, Mu Delta and PPD 10558. Priligy (dapoxetine) is a drug developed for the on-demand treatment of premature ejaculation (PE). Dapoxetine is a short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed one to three hours before sexual intercourse is anticipated rather than every day. Nesina (alogliptin) is a drug for the oral treatment of type 2 diabetes (T2D). In November 2011, it acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V.

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/21/2011 8:25 AM Buy
14.82 18.00
as of 12/30/2011
1 Week down  -0.77 %
1 Month down  -7.16 %
3 Months up  12.75 %
1 YTD up  12.75 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy